Our study also demonstrated that serum levels of CCL18 had moderate discriminatory ability for differentiating IPF patients from the HC; however, CCL18 was found to be a poor indicator for distinguishing IPF from BP. The gene discussed is CCL18; the disease is idiopathic pulmonary fibrosis.